Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, T-Cell, Cutaneous | 35 | 2024 | 209 | 5.280 |
Why?
|
Skin | 73 | 2022 | 4466 | 3.590 |
Why?
|
Immunologic Memory | 22 | 2022 | 1354 | 3.480 |
Why?
|
Mycosis Fungoides | 14 | 2024 | 168 | 3.140 |
Why?
|
T-Lymphocytes | 55 | 2022 | 10181 | 2.940 |
Why?
|
T-Lymphocyte Subsets | 16 | 2022 | 1810 | 2.160 |
Why?
|
Interleukin-1 | 35 | 2005 | 1249 | 2.160 |
Why?
|
Skin Neoplasms | 45 | 2024 | 5799 | 2.120 |
Why?
|
Keratinocytes | 30 | 2015 | 792 | 1.930 |
Why?
|
Epidermis | 27 | 2012 | 529 | 1.710 |
Why?
|
Skin Diseases | 16 | 2022 | 1089 | 1.690 |
Why?
|
Sezary Syndrome | 6 | 2024 | 78 | 1.430 |
Why?
|
Vaccinia virus | 10 | 2019 | 331 | 1.400 |
Why?
|
CD8-Positive T-Lymphocytes | 16 | 2023 | 4550 | 1.270 |
Why?
|
E-Selectin | 18 | 2012 | 576 | 1.240 |
Why?
|
Dermatitis, Contact | 11 | 2017 | 133 | 1.190 |
Why?
|
Membrane Glycoproteins | 20 | 2014 | 3707 | 1.190 |
Why?
|
Psoriasis | 16 | 2017 | 940 | 1.150 |
Why?
|
Sewage | 8 | 2008 | 41 | 1.070 |
Why?
|
Langerhans Cells | 7 | 2013 | 171 | 0.950 |
Why?
|
Receptors, CCR4 | 8 | 2014 | 77 | 0.930 |
Why?
|
Dermatitis | 9 | 2016 | 200 | 0.920 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 5 | 2019 | 345 | 0.880 |
Why?
|
Waste Disposal, Fluid | 6 | 2008 | 31 | 0.840 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 19 | 2015 | 899 | 0.810 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2022 | 96 | 0.770 |
Why?
|
Genes, T-Cell Receptor beta | 3 | 2018 | 71 | 0.760 |
Why?
|
Interleukin-1alpha | 2 | 2020 | 86 | 0.760 |
Why?
|
T-Lymphocytes, Regulatory | 13 | 2015 | 3075 | 0.760 |
Why?
|
Receptors, Lymphocyte Homing | 9 | 2018 | 141 | 0.750 |
Why?
|
Receptors, Interleukin-1 | 12 | 2005 | 261 | 0.720 |
Why?
|
Antigens, Neoplasm | 20 | 2014 | 1998 | 0.670 |
Why?
|
Interleukin-17 | 5 | 2020 | 910 | 0.670 |
Why?
|
Lymphoma, T-Cell | 5 | 2023 | 305 | 0.650 |
Why?
|
Dermis | 3 | 2017 | 202 | 0.630 |
Why?
|
Receptors, Antigen, T-Cell | 9 | 2017 | 2536 | 0.620 |
Why?
|
CD4-Positive T-Lymphocytes | 12 | 2022 | 4353 | 0.600 |
Why?
|
Adaptive Immunity | 2 | 2020 | 726 | 0.590 |
Why?
|
T-Lymphocytes, Cytotoxic | 4 | 2015 | 1765 | 0.590 |
Why?
|
Immunity, Cellular | 8 | 2010 | 1557 | 0.590 |
Why?
|
Immunologic Surveillance | 3 | 2006 | 92 | 0.580 |
Why?
|
Th17 Cells | 3 | 2020 | 787 | 0.580 |
Why?
|
Dermatitis, Allergic Contact | 2 | 2015 | 111 | 0.570 |
Why?
|
Mice | 94 | 2022 | 81208 | 0.560 |
Why?
|
Inflammation | 19 | 2019 | 10756 | 0.550 |
Why?
|
Dermatology | 6 | 2018 | 914 | 0.540 |
Why?
|
Interleukins | 9 | 2017 | 785 | 0.540 |
Why?
|
Melanoma | 10 | 2022 | 5697 | 0.530 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 3 | 2017 | 801 | 0.520 |
Why?
|
Lymphocyte Activation | 22 | 2014 | 5496 | 0.520 |
Why?
|
Animals | 118 | 2022 | 167963 | 0.510 |
Why?
|
Cells, Cultured | 41 | 2020 | 18957 | 0.500 |
Why?
|
Candida albicans | 2 | 2017 | 374 | 0.500 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2017 | 393 | 0.500 |
Why?
|
Candidiasis | 1 | 2017 | 363 | 0.490 |
Why?
|
Smallpox Vaccine | 2 | 2013 | 77 | 0.490 |
Why?
|
Cell Movement | 18 | 2017 | 5206 | 0.480 |
Why?
|
Gene Expression Profiling | 9 | 2021 | 9411 | 0.480 |
Why?
|
Poxviridae | 2 | 2015 | 37 | 0.470 |
Why?
|
Vaccinia | 4 | 2017 | 71 | 0.470 |
Why?
|
Vaccines | 1 | 2023 | 832 | 0.470 |
Why?
|
Neutrophil Infiltration | 1 | 2017 | 393 | 0.460 |
Why?
|
Dendritic Cells | 12 | 2020 | 2725 | 0.460 |
Why?
|
Interleukin-1beta | 1 | 2020 | 998 | 0.460 |
Why?
|
Soil | 4 | 2008 | 109 | 0.450 |
Why?
|
Smallpox | 1 | 2013 | 43 | 0.440 |
Why?
|
Antibodies, Monoclonal | 13 | 2020 | 9185 | 0.440 |
Why?
|
Keratins | 13 | 2004 | 497 | 0.440 |
Why?
|
Janus Kinases | 1 | 2014 | 250 | 0.430 |
Why?
|
Interleukin-9 | 2 | 2014 | 61 | 0.430 |
Why?
|
Mice, Transgenic | 27 | 2016 | 9530 | 0.430 |
Why?
|
Allergy and Immunology | 1 | 2014 | 175 | 0.420 |
Why?
|
Water Pollutants, Chemical | 5 | 2009 | 354 | 0.420 |
Why?
|
Cytokines | 22 | 2014 | 7343 | 0.420 |
Why?
|
Ultraviolet Rays | 7 | 2006 | 1078 | 0.420 |
Why?
|
Viral Vaccines | 2 | 2010 | 596 | 0.420 |
Why?
|
Flame Retardants | 3 | 2009 | 93 | 0.420 |
Why?
|
Immunity, Innate | 9 | 2019 | 3047 | 0.420 |
Why?
|
P-Selectin | 12 | 2012 | 599 | 0.410 |
Why?
|
Refuse Disposal | 4 | 2008 | 31 | 0.410 |
Why?
|
Cell Separation | 7 | 2013 | 1720 | 0.410 |
Why?
|
Antigens | 4 | 2012 | 1447 | 0.400 |
Why?
|
Dermatitis, Atopic | 7 | 2021 | 716 | 0.400 |
Why?
|
Alopecia Areata | 1 | 2014 | 127 | 0.400 |
Why?
|
Immunotherapy, Active | 1 | 2012 | 59 | 0.390 |
Why?
|
Interleukin-7 | 2 | 2005 | 142 | 0.390 |
Why?
|
Humans | 185 | 2024 | 760621 | 0.390 |
Why?
|
Cell Adhesion Molecules | 8 | 2005 | 1602 | 0.390 |
Why?
|
Flow Cytometry | 21 | 2015 | 5870 | 0.380 |
Why?
|
Neutrophils | 5 | 2017 | 3767 | 0.380 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2022 | 3616 | 0.380 |
Why?
|
Aminoquinolines | 3 | 2009 | 108 | 0.380 |
Why?
|
Contraceptive Agents | 1 | 2012 | 145 | 0.380 |
Why?
|
Pesticides | 3 | 2008 | 293 | 0.360 |
Why?
|
Immunity | 2 | 2015 | 998 | 0.360 |
Why?
|
Antibody Formation | 5 | 2005 | 1400 | 0.350 |
Why?
|
Clone Cells | 9 | 2022 | 1660 | 0.350 |
Why?
|
Papilloma | 3 | 2003 | 141 | 0.350 |
Why?
|
Mice, Inbred C57BL | 23 | 2022 | 22023 | 0.350 |
Why?
|
Mice, SCID | 8 | 2020 | 2627 | 0.350 |
Why?
|
Integrins | 6 | 1995 | 839 | 0.350 |
Why?
|
Antigens, CD | 11 | 2015 | 4000 | 0.350 |
Why?
|
Tumor Microenvironment | 2 | 2020 | 3844 | 0.350 |
Why?
|
Gene Expression Regulation, Neoplastic | 11 | 2018 | 8515 | 0.340 |
Why?
|
Interleukin-2 | 13 | 2015 | 1889 | 0.340 |
Why?
|
Mice, Knockout | 14 | 2020 | 14372 | 0.340 |
Why?
|
Graft vs Host Disease | 3 | 2020 | 3025 | 0.340 |
Why?
|
Growth Substances | 8 | 1996 | 768 | 0.340 |
Why?
|
Immune System | 6 | 2015 | 798 | 0.330 |
Why?
|
Models, Immunological | 6 | 2015 | 513 | 0.330 |
Why?
|
Receptors, Chemokine | 4 | 2006 | 655 | 0.330 |
Why?
|
Biological Factors | 5 | 1990 | 157 | 0.320 |
Why?
|
Interleukin-15 | 2 | 2006 | 183 | 0.320 |
Why?
|
Interleukin-16 | 3 | 2014 | 34 | 0.310 |
Why?
|
Lipid Metabolism | 2 | 2017 | 1902 | 0.310 |
Why?
|
Th2 Cells | 4 | 2013 | 1047 | 0.310 |
Why?
|
Disinfectants | 2 | 2007 | 130 | 0.310 |
Why?
|
Receptors, Very Late Antigen | 3 | 1993 | 74 | 0.310 |
Why?
|
T-Lymphocytes, Helper-Inducer | 8 | 2014 | 975 | 0.300 |
Why?
|
Neoplasm Proteins | 5 | 2017 | 3610 | 0.300 |
Why?
|
Gene Expression | 13 | 2023 | 7588 | 0.300 |
Why?
|
Interferon-gamma | 7 | 2020 | 3157 | 0.290 |
Why?
|
Monocytes | 5 | 2005 | 2575 | 0.290 |
Why?
|
Caspase 1 | 2 | 2006 | 226 | 0.290 |
Why?
|
Cell Proliferation | 8 | 2016 | 10446 | 0.280 |
Why?
|
Neoplasms | 4 | 2020 | 22072 | 0.280 |
Why?
|
Fatty Acid-Binding Proteins | 2 | 2020 | 296 | 0.280 |
Why?
|
Adoptive Transfer | 2 | 2013 | 822 | 0.280 |
Why?
|
Polycyclic Compounds | 1 | 2006 | 29 | 0.270 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 4 | 2020 | 1088 | 0.270 |
Why?
|
Interleukin-18 | 2 | 2006 | 251 | 0.270 |
Why?
|
Lymphoproliferative Disorders | 2 | 2022 | 533 | 0.270 |
Why?
|
Colony-Stimulating Factors | 5 | 1990 | 218 | 0.270 |
Why?
|
Carcinoma, Squamous Cell | 8 | 2009 | 4024 | 0.260 |
Why?
|
Fibroblasts | 8 | 2006 | 4090 | 0.260 |
Why?
|
Lymph Nodes | 7 | 2018 | 3486 | 0.260 |
Why?
|
Interleukin-12 | 3 | 2006 | 584 | 0.260 |
Why?
|
Recombinant Fusion Proteins | 5 | 2012 | 3735 | 0.260 |
Why?
|
Tumor Escape | 1 | 2008 | 370 | 0.250 |
Why?
|
Sialoglycoproteins | 4 | 2005 | 315 | 0.250 |
Why?
|
Estradiol | 1 | 2012 | 1932 | 0.250 |
Why?
|
Tetradecanoylphorbol Acetate | 7 | 2003 | 818 | 0.250 |
Why?
|
Vitamin A | 2 | 2007 | 613 | 0.250 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2006 | 585 | 0.240 |
Why?
|
Immune Tolerance | 9 | 2009 | 2299 | 0.240 |
Why?
|
Antigen-Presenting Cells | 5 | 2020 | 967 | 0.240 |
Why?
|
Up-Regulation | 7 | 2020 | 4122 | 0.230 |
Why?
|
Keratin-14 | 6 | 2009 | 56 | 0.230 |
Why?
|
Epitopes | 1 | 2011 | 2503 | 0.230 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2001 | 1407 | 0.230 |
Why?
|
Mice, Inbred NOD | 6 | 2020 | 1837 | 0.230 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 5 | 2017 | 298 | 0.230 |
Why?
|
RNA, Messenger | 19 | 2015 | 12766 | 0.230 |
Why?
|
Immunity, Active | 1 | 2003 | 58 | 0.220 |
Why?
|
Antineoplastic Agents | 10 | 2016 | 13630 | 0.220 |
Why?
|
Cellulitis | 2 | 2016 | 207 | 0.220 |
Why?
|
Interferon-alpha | 2 | 2010 | 918 | 0.220 |
Why?
|
L-Selectin | 4 | 2010 | 209 | 0.220 |
Why?
|
Forkhead Transcription Factors | 5 | 2010 | 1612 | 0.220 |
Why?
|
Autoantigens | 2 | 2005 | 877 | 0.220 |
Why?
|
Platelet Membrane Glycoproteins | 2 | 1994 | 285 | 0.220 |
Why?
|
Receptors, CXCR4 | 3 | 2021 | 728 | 0.220 |
Why?
|
Hair Follicle | 3 | 2016 | 210 | 0.220 |
Why?
|
Photopheresis | 1 | 2003 | 35 | 0.220 |
Why?
|
Cell Adhesion | 12 | 2007 | 3094 | 0.210 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2004 | 190 | 0.210 |
Why?
|
Monitoring, Immunologic | 3 | 2018 | 98 | 0.210 |
Why?
|
Soil Pollutants | 3 | 2007 | 70 | 0.210 |
Why?
|
Immunocompetence | 2 | 2017 | 138 | 0.210 |
Why?
|
Adjuvants, Immunologic | 2 | 2003 | 1039 | 0.210 |
Why?
|
Cholecalciferol | 1 | 2007 | 550 | 0.210 |
Why?
|
Burns | 10 | 1996 | 1866 | 0.200 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5649 | 0.200 |
Why?
|
Mouth Mucosa | 1 | 2004 | 426 | 0.200 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2023 | 124 | 0.200 |
Why?
|
Receptors, CCR7 | 2 | 2013 | 107 | 0.200 |
Why?
|
Cell Division | 13 | 2016 | 4463 | 0.200 |
Why?
|
Exotoxins | 1 | 2022 | 121 | 0.200 |
Why?
|
Endothelium, Vascular | 8 | 2005 | 4433 | 0.190 |
Why?
|
Neoplasm Staging | 7 | 2019 | 11152 | 0.190 |
Why?
|
Mucin-1 | 2 | 2017 | 539 | 0.190 |
Why?
|
Disease Models, Animal | 13 | 2020 | 18137 | 0.190 |
Why?
|
Phenotype | 15 | 2019 | 16546 | 0.190 |
Why?
|
Polychlorinated Biphenyls | 4 | 2007 | 235 | 0.190 |
Why?
|
Female | 60 | 2024 | 391270 | 0.190 |
Why?
|
Immunization | 3 | 2015 | 1227 | 0.190 |
Why?
|
Intercellular Adhesion Molecule-1 | 6 | 2007 | 1126 | 0.190 |
Why?
|
Ligands | 6 | 2010 | 3276 | 0.190 |
Why?
|
Interleukin-13 | 2 | 2013 | 371 | 0.180 |
Why?
|
Neoplasm Transplantation | 4 | 2018 | 2014 | 0.180 |
Why?
|
Myasthenia Gravis | 1 | 2023 | 213 | 0.180 |
Why?
|
Macrophages | 8 | 2006 | 5745 | 0.180 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2012 | 4357 | 0.180 |
Why?
|
Carcinoma, Basal Cell | 2 | 2003 | 559 | 0.180 |
Why?
|
Receptors, Retinoic Acid | 1 | 2001 | 224 | 0.180 |
Why?
|
Immunophenotyping | 5 | 2015 | 1871 | 0.180 |
Why?
|
Hydrocarbons, Brominated | 3 | 2009 | 29 | 0.180 |
Why?
|
Myositis | 1 | 2023 | 269 | 0.180 |
Why?
|
Antigens, Dermatophagoides | 1 | 2020 | 97 | 0.180 |
Why?
|
Chemokine CCL22 | 3 | 2014 | 27 | 0.170 |
Why?
|
B-Lymphocyte Subsets | 1 | 2001 | 241 | 0.170 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 2 | 2015 | 305 | 0.170 |
Why?
|
Recombinant Proteins | 17 | 2005 | 6538 | 0.170 |
Why?
|
Cell Line, Tumor | 10 | 2020 | 16939 | 0.170 |
Why?
|
Biopsy | 7 | 2019 | 6771 | 0.170 |
Why?
|
Anaerobiosis | 3 | 2008 | 139 | 0.170 |
Why?
|
Mice, Inbred BALB C | 9 | 2018 | 6216 | 0.170 |
Why?
|
Periodontitis | 1 | 2004 | 560 | 0.170 |
Why?
|
Fucosyltransferases | 2 | 2018 | 117 | 0.170 |
Why?
|
Lectins, C-Type | 3 | 2015 | 587 | 0.170 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 7 | 1997 | 886 | 0.160 |
Why?
|
Th1 Cells | 3 | 2013 | 1032 | 0.160 |
Why?
|
Male | 61 | 2024 | 359744 | 0.160 |
Why?
|
Chemokine CXCL12 | 1 | 2021 | 454 | 0.160 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2010 | 3604 | 0.160 |
Why?
|
Prognosis | 8 | 2019 | 29658 | 0.160 |
Why?
|
Scleroderma, Systemic | 3 | 2005 | 344 | 0.160 |
Why?
|
Dipeptidyl Peptidase 4 | 2 | 2010 | 92 | 0.160 |
Why?
|
Biodegradation, Environmental | 3 | 2008 | 218 | 0.160 |
Why?
|
Integrin beta Chains | 1 | 2018 | 115 | 0.160 |
Why?
|
Alopecia | 2 | 2000 | 414 | 0.150 |
Why?
|
Cell Differentiation | 5 | 2017 | 11481 | 0.150 |
Why?
|
Nucleotides, Cyclic | 1 | 2019 | 84 | 0.150 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5643 | 0.150 |
Why?
|
Switzerland | 7 | 2009 | 323 | 0.150 |
Why?
|
Vaccination | 3 | 2023 | 3361 | 0.150 |
Why?
|
Methotrexate | 1 | 2004 | 1719 | 0.150 |
Why?
|
Deoxyribonucleases | 1 | 2019 | 212 | 0.150 |
Why?
|
Lymphokines | 5 | 1988 | 927 | 0.150 |
Why?
|
Natural Killer T-Cells | 1 | 2021 | 311 | 0.150 |
Why?
|
Lymphocyte Count | 3 | 2012 | 780 | 0.150 |
Why?
|
Interleukin-6 | 7 | 2015 | 3215 | 0.150 |
Why?
|
Neoplastic Stem Cells | 3 | 2011 | 1347 | 0.150 |
Why?
|
Interleukin-10 | 4 | 2009 | 1175 | 0.150 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 2010 | 94 | 0.140 |
Why?
|
Apoptosis | 6 | 2017 | 9501 | 0.140 |
Why?
|
Focal Dermal Hypoplasia | 1 | 2016 | 8 | 0.140 |
Why?
|
Selectins | 1 | 1997 | 101 | 0.140 |
Why?
|
Collagen | 4 | 1995 | 2636 | 0.140 |
Why?
|
Pruritus | 2 | 2017 | 377 | 0.140 |
Why?
|
Leukemia | 2 | 2016 | 1520 | 0.140 |
Why?
|
Mast Cells | 3 | 2012 | 1390 | 0.140 |
Why?
|
HLA-DR Antigens | 2 | 2015 | 630 | 0.140 |
Why?
|
Skin Diseases, Infectious | 1 | 2017 | 77 | 0.140 |
Why?
|
Nucleotidyltransferases | 1 | 2019 | 244 | 0.140 |
Why?
|
Brachytherapy | 2 | 2016 | 1238 | 0.140 |
Why?
|
Receptors, Interleukin | 2 | 2012 | 243 | 0.140 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2022 | 2828 | 0.140 |
Why?
|
Endotoxins | 4 | 1994 | 521 | 0.140 |
Why?
|
Allied Health Personnel | 1 | 2018 | 156 | 0.140 |
Why?
|
Middle Aged | 36 | 2022 | 220352 | 0.140 |
Why?
|
Mucins | 2 | 2022 | 568 | 0.140 |
Why?
|
Cell Cycle | 3 | 2016 | 2934 | 0.140 |
Why?
|
Chemokines, CC | 3 | 2004 | 283 | 0.140 |
Why?
|
Interleukin-4 | 5 | 2013 | 1130 | 0.130 |
Why?
|
Receptors, CCR6 | 2 | 2006 | 73 | 0.130 |
Why?
|
Cell Migration Assays | 1 | 2016 | 21 | 0.130 |
Why?
|
Disease Management | 2 | 2019 | 2514 | 0.130 |
Why?
|
Administration, Cutaneous | 3 | 2017 | 713 | 0.130 |
Why?
|
Amino Acid Sequence | 8 | 2017 | 13451 | 0.130 |
Why?
|
Transforming Growth Factor beta | 5 | 2014 | 1959 | 0.130 |
Why?
|
Foot Dermatoses | 1 | 2016 | 47 | 0.130 |
Why?
|
Hand Dermatoses | 1 | 2016 | 62 | 0.130 |
Why?
|
Myocarditis | 1 | 2023 | 766 | 0.130 |
Why?
|
Erythema | 2 | 2014 | 262 | 0.130 |
Why?
|
Aged, 80 and over | 16 | 2019 | 58995 | 0.130 |
Why?
|
Agriculture | 2 | 2007 | 190 | 0.130 |
Why?
|
Azacitidine | 1 | 2017 | 334 | 0.130 |
Why?
|
Granzymes | 2 | 2015 | 276 | 0.130 |
Why?
|
Cephalexin | 1 | 2015 | 38 | 0.130 |
Why?
|
Haptens | 1 | 2015 | 163 | 0.120 |
Why?
|
Tissue Banks | 1 | 2016 | 184 | 0.120 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2017 | 3584 | 0.120 |
Why?
|
Interleukin-7 Receptor alpha Subunit | 1 | 2015 | 50 | 0.120 |
Why?
|
Antigens, Surface | 2 | 2013 | 1608 | 0.120 |
Why?
|
Case-Control Studies | 10 | 2024 | 22053 | 0.120 |
Why?
|
Hamartoma | 1 | 1997 | 235 | 0.120 |
Why?
|
Adult | 28 | 2020 | 219994 | 0.120 |
Why?
|
Molecular Weight | 7 | 2007 | 2186 | 0.120 |
Why?
|
Radiotherapy | 2 | 2019 | 1504 | 0.120 |
Why?
|
Disease Progression | 8 | 2020 | 13502 | 0.120 |
Why?
|
Chemokines, CXC | 1 | 1996 | 421 | 0.120 |
Why?
|
Documentation | 2 | 2018 | 893 | 0.120 |
Why?
|
Cyclophosphamide | 4 | 2004 | 2221 | 0.120 |
Why?
|
Interleukin-3 | 2 | 1993 | 425 | 0.120 |
Why?
|
Disease Susceptibility | 3 | 2019 | 1791 | 0.120 |
Why?
|
STAT4 Transcription Factor | 1 | 2014 | 93 | 0.110 |
Why?
|
Oxidation-Reduction | 2 | 2017 | 2222 | 0.110 |
Why?
|
Skin Physiological Phenomena | 3 | 1992 | 188 | 0.110 |
Why?
|
Leukocytes | 4 | 1997 | 2026 | 0.110 |
Why?
|
Genetic Markers | 1 | 2020 | 2608 | 0.110 |
Why?
|
Environmental Monitoring | 5 | 2007 | 1441 | 0.110 |
Why?
|
Cell Survival | 3 | 2017 | 5797 | 0.110 |
Why?
|
Transcription Factors | 4 | 2012 | 12103 | 0.110 |
Why?
|
Morpholines | 1 | 2017 | 583 | 0.110 |
Why?
|
Extracellular Matrix | 2 | 1991 | 1726 | 0.110 |
Why?
|
Immunoglobulin G | 3 | 2012 | 4541 | 0.110 |
Why?
|
Coculture Techniques | 4 | 2020 | 1342 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 4573 | 0.110 |
Why?
|
Piperidines | 1 | 2022 | 1650 | 0.110 |
Why?
|
Mannose-Binding Lectins | 1 | 2013 | 96 | 0.110 |
Why?
|
Chemotaxis | 3 | 2012 | 598 | 0.110 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 1933 | 0.110 |
Why?
|
Homeostasis | 5 | 2012 | 3306 | 0.110 |
Why?
|
Suntan | 1 | 2012 | 17 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2012 | 43 | 0.110 |
Why?
|
Chemokine CCL2 | 1 | 1995 | 605 | 0.110 |
Why?
|
Autocrine Communication | 1 | 2014 | 169 | 0.110 |
Why?
|
Bone Diseases | 1 | 2016 | 419 | 0.110 |
Why?
|
HMGB1 Protein | 1 | 2014 | 137 | 0.110 |
Why?
|
Chemotaxis, Leukocyte | 2 | 2013 | 663 | 0.110 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 1994 | 263 | 0.110 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 2 | 2003 | 58 | 0.100 |
Why?
|
Down-Regulation | 3 | 2010 | 2913 | 0.100 |
Why?
|
Aged | 26 | 2024 | 169152 | 0.100 |
Why?
|
Blotting, Western | 7 | 2015 | 5039 | 0.100 |
Why?
|
Radiation Chimera | 1 | 2012 | 216 | 0.100 |
Why?
|
Biological Transport | 1 | 2017 | 2086 | 0.100 |
Why?
|
Lung | 2 | 2011 | 9994 | 0.100 |
Why?
|
Panniculitis | 1 | 2012 | 45 | 0.100 |
Why?
|
Paracrine Communication | 1 | 2014 | 277 | 0.100 |
Why?
|
Thymus Gland | 3 | 2005 | 1247 | 0.100 |
Why?
|
Clinical Enzyme Tests | 1 | 2012 | 115 | 0.100 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2012 | 107 | 0.100 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8552 | 0.100 |
Why?
|
Molecular Sequence Data | 11 | 2012 | 17624 | 0.100 |
Why?
|
Protein Binding | 6 | 2017 | 9335 | 0.100 |
Why?
|
Fibronectins | 3 | 1993 | 722 | 0.100 |
Why?
|
Facial Neoplasms | 1 | 2013 | 125 | 0.100 |
Why?
|
Leukemia, T-Cell | 1 | 2012 | 101 | 0.100 |
Why?
|
Single-Chain Antibodies | 1 | 2012 | 111 | 0.100 |
Why?
|
Subcutaneous Tissue | 1 | 2012 | 132 | 0.100 |
Why?
|
Immunoglobulin Fc Fragments | 2 | 2012 | 280 | 0.100 |
Why?
|
Protein C | 1 | 2012 | 133 | 0.100 |
Why?
|
Glycoproteins | 2 | 2012 | 2208 | 0.100 |
Why?
|
Diagnosis-Related Groups | 1 | 2013 | 450 | 0.100 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2012 | 144 | 0.100 |
Why?
|
Vitreous Body | 1 | 1993 | 399 | 0.100 |
Why?
|
Cell Growth Processes | 1 | 2012 | 384 | 0.100 |
Why?
|
Polybrominated Biphenyls | 2 | 2007 | 25 | 0.090 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2012 | 303 | 0.090 |
Why?
|
Cancer Vaccines | 2 | 2012 | 1046 | 0.090 |
Why?
|
Galectin 1 | 1 | 2012 | 128 | 0.090 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 257 | 0.090 |
Why?
|
Receptors, Immunologic | 4 | 1990 | 1411 | 0.090 |
Why?
|
Blood Coagulation Tests | 1 | 2012 | 270 | 0.090 |
Why?
|
Antigenic Variation | 1 | 2011 | 118 | 0.090 |
Why?
|
Immunosuppressive Agents | 1 | 2003 | 4166 | 0.090 |
Why?
|
Receptors, CCR10 | 1 | 2010 | 9 | 0.090 |
Why?
|
Nevus, Halo | 1 | 2010 | 5 | 0.090 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2012 | 259 | 0.090 |
Why?
|
Aptamers, Nucleotide | 1 | 2012 | 172 | 0.090 |
Why?
|
Transgenes | 3 | 2006 | 1006 | 0.090 |
Why?
|
Mice, Inbred C3H | 5 | 2015 | 915 | 0.090 |
Why?
|
Dihydroxycholecalciferols | 1 | 2010 | 17 | 0.090 |
Why?
|
Chemokine CCL21 | 1 | 2010 | 50 | 0.090 |
Why?
|
Protein Precursors | 2 | 2011 | 1134 | 0.090 |
Why?
|
Polyomavirus Infections | 1 | 2012 | 194 | 0.090 |
Why?
|
Protein Processing, Post-Translational | 3 | 1997 | 1974 | 0.090 |
Why?
|
Cecum | 1 | 1991 | 232 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2020 | 3775 | 0.090 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2011 | 435 | 0.090 |
Why?
|
Macrophage-1 Antigen | 1 | 1991 | 286 | 0.090 |
Why?
|
Antigens, Differentiation | 2 | 2006 | 911 | 0.090 |
Why?
|
Bacterial Infections | 2 | 1991 | 1403 | 0.090 |
Why?
|
Carcinogens | 2 | 2003 | 449 | 0.090 |
Why?
|
Cell Line | 14 | 2019 | 15620 | 0.090 |
Why?
|
Pyrimidines | 1 | 2022 | 3016 | 0.090 |
Why?
|
Homeodomain Proteins | 2 | 2012 | 2414 | 0.090 |
Why?
|
Histocompatibility Antigens Class II | 4 | 1998 | 1446 | 0.090 |
Why?
|
DNA Primers | 4 | 2012 | 2819 | 0.090 |
Why?
|
Validation Studies as Topic | 1 | 2010 | 162 | 0.090 |
Why?
|
Melanoma, Experimental | 2 | 2012 | 562 | 0.080 |
Why?
|
Tumor Virus Infections | 1 | 2012 | 438 | 0.080 |
Why?
|
Tumor Burden | 2 | 2013 | 1895 | 0.080 |
Why?
|
Gene Expression Regulation | 7 | 2015 | 11903 | 0.080 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2015 | 556 | 0.080 |
Why?
|
Biological Products | 3 | 1987 | 916 | 0.080 |
Why?
|
Immunohistochemistry | 8 | 2012 | 11071 | 0.080 |
Why?
|
Trout | 1 | 2009 | 20 | 0.080 |
Why?
|
Oxazolone | 2 | 1999 | 61 | 0.080 |
Why?
|
Mice, Inbred Strains | 4 | 2000 | 1763 | 0.080 |
Why?
|
Diphtheria Toxin | 1 | 2010 | 252 | 0.080 |
Why?
|
Vitiligo | 1 | 2010 | 98 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 1996 | 1652 | 0.080 |
Why?
|
Oxidative Stress | 2 | 2017 | 3106 | 0.080 |
Why?
|
Blood Circulation | 1 | 2010 | 249 | 0.080 |
Why?
|
Heat-Shock Proteins | 1 | 2012 | 795 | 0.080 |
Why?
|
Halogenated Diphenyl Ethers | 1 | 2009 | 83 | 0.080 |
Why?
|
Virus Replication | 3 | 2019 | 2432 | 0.080 |
Why?
|
Lymphoma | 2 | 2016 | 1898 | 0.080 |
Why?
|
Signal Transduction | 7 | 2019 | 23376 | 0.080 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2012 | 321 | 0.080 |
Why?
|
Oncogene Proteins | 1 | 2012 | 719 | 0.080 |
Why?
|
Specialization | 1 | 2013 | 778 | 0.080 |
Why?
|
Actins | 1 | 1995 | 2049 | 0.080 |
Why?
|
Edema | 1 | 2012 | 769 | 0.080 |
Why?
|
Eye Diseases | 1 | 1993 | 651 | 0.080 |
Why?
|
Microcirculation | 3 | 2005 | 1278 | 0.070 |
Why?
|
Tumor Cells, Cultured | 5 | 2015 | 6131 | 0.070 |
Why?
|
Cicatrix | 1 | 2013 | 782 | 0.070 |
Why?
|
Cycloheximide | 1 | 1988 | 343 | 0.070 |
Why?
|
Polymerase Chain Reaction | 6 | 2008 | 6068 | 0.070 |
Why?
|
Drug Eruptions | 1 | 1991 | 335 | 0.070 |
Why?
|
Interviews as Topic | 1 | 2015 | 2659 | 0.070 |
Why?
|
Treatment Outcome | 9 | 2022 | 65017 | 0.070 |
Why?
|
Food Contamination | 1 | 2009 | 192 | 0.070 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 916 | 0.070 |
Why?
|
Genetic Testing | 2 | 2015 | 3531 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 558 | 0.070 |
Why?
|
Waste Products | 1 | 2007 | 12 | 0.070 |
Why?
|
Ovalbumin | 1 | 2009 | 674 | 0.070 |
Why?
|
Extracellular Matrix Proteins | 1 | 1991 | 829 | 0.070 |
Why?
|
Microfilament Proteins | 1 | 2012 | 1135 | 0.070 |
Why?
|
Anti-Bacterial Agents | 2 | 2016 | 7408 | 0.070 |
Why?
|
Femoral Fractures | 1 | 1991 | 375 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 2 | 2015 | 6544 | 0.070 |
Why?
|
Membrane Proteins | 4 | 2019 | 7850 | 0.070 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2008 | 514 | 0.070 |
Why?
|
Construction Materials | 1 | 2007 | 60 | 0.070 |
Why?
|
Glucocorticoid-Induced TNFR-Related Protein | 1 | 2006 | 40 | 0.070 |
Why?
|
Proteins | 2 | 2014 | 6029 | 0.070 |
Why?
|
Metalloendopeptidases | 2 | 2001 | 393 | 0.070 |
Why?
|
Endothelium | 3 | 1999 | 764 | 0.070 |
Why?
|
Chemokine CCL17 | 2 | 2004 | 26 | 0.070 |
Why?
|
Remission Induction | 2 | 2010 | 2392 | 0.070 |
Why?
|
Serine Endopeptidases | 1 | 1991 | 1021 | 0.070 |
Why?
|
Lymphoid Tissue | 1 | 1988 | 445 | 0.070 |
Why?
|
Organic Chemicals | 1 | 2007 | 211 | 0.070 |
Why?
|
Picibanil | 1 | 2005 | 10 | 0.070 |
Why?
|
Transduction, Genetic | 2 | 2012 | 897 | 0.070 |
Why?
|
Dermatologic Agents | 1 | 2010 | 307 | 0.060 |
Why?
|
Clonal Deletion | 1 | 2005 | 74 | 0.060 |
Why?
|
Tretinoin | 2 | 1989 | 519 | 0.060 |
Why?
|
Base Sequence | 6 | 2017 | 12446 | 0.060 |
Why?
|
Peptides | 2 | 2015 | 4354 | 0.060 |
Why?
|
Leg Ulcer | 1 | 2005 | 70 | 0.060 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 2005 | 111 | 0.060 |
Why?
|
Patient Admission | 1 | 2013 | 1386 | 0.060 |
Why?
|
Insecticides | 1 | 2007 | 191 | 0.060 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2016 | 223 | 0.060 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2006 | 198 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2018 | 3448 | 0.060 |
Why?
|
Monitoring, Intraoperative | 1 | 2012 | 942 | 0.060 |
Why?
|
Plants | 1 | 2007 | 317 | 0.060 |
Why?
|
Wound Infection | 1 | 1987 | 244 | 0.060 |
Why?
|
Vaccines, Attenuated | 1 | 2006 | 314 | 0.060 |
Why?
|
Perfume | 1 | 2004 | 9 | 0.060 |
Why?
|
Receptors, Cytokine | 2 | 2014 | 258 | 0.060 |
Why?
|
Receptors, Interleukin-2 | 1 | 2006 | 562 | 0.060 |
Why?
|
Self Tolerance | 1 | 2005 | 124 | 0.060 |
Why?
|
Neutrophil Activation | 1 | 2005 | 181 | 0.060 |
Why?
|
Paired Box Transcription Factors | 1 | 2005 | 207 | 0.060 |
Why?
|
Lymphocyte Culture Test, Mixed | 5 | 2003 | 516 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 3804 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2014 | 5791 | 0.060 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2004 | 31 | 0.060 |
Why?
|
Interphase | 2 | 2003 | 228 | 0.060 |
Why?
|
Gene Knockdown Techniques | 3 | 2015 | 1617 | 0.060 |
Why?
|
Sunscreening Agents | 1 | 2005 | 139 | 0.060 |
Why?
|
Carcinoma | 1 | 1996 | 2331 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12159 | 0.060 |
Why?
|
Benzofurans | 1 | 2005 | 142 | 0.060 |
Why?
|
Stress, Mechanical | 2 | 2001 | 1666 | 0.060 |
Why?
|
Lymphatic Metastasis | 1 | 2012 | 2943 | 0.060 |
Why?
|
Adenosine Deaminase | 1 | 2006 | 251 | 0.060 |
Why?
|
Antigen Presentation | 3 | 2003 | 1254 | 0.060 |
Why?
|
Statistical Distributions | 1 | 2004 | 63 | 0.060 |
Why?
|
CHO Cells | 3 | 2002 | 1389 | 0.060 |
Why?
|
Blood | 1 | 2006 | 586 | 0.060 |
Why?
|
Cell Lineage | 2 | 2016 | 2533 | 0.060 |
Why?
|
Antibodies, Viral | 2 | 2012 | 3143 | 0.060 |
Why?
|
Jurkat Cells | 1 | 2005 | 736 | 0.060 |
Why?
|
Cell Polarity | 2 | 2020 | 638 | 0.060 |
Why?
|
Escherichia coli Proteins | 1 | 2010 | 1066 | 0.060 |
Why?
|
CD4-CD8 Ratio | 1 | 2003 | 114 | 0.060 |
Why?
|
Molecular Structure | 1 | 2008 | 1895 | 0.060 |
Why?
|
Dental Plaque | 1 | 2004 | 209 | 0.060 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2005 | 590 | 0.060 |
Why?
|
Infant, Newborn | 5 | 2018 | 26181 | 0.050 |
Why?
|
Microscopy, Immunoelectron | 1 | 2003 | 317 | 0.050 |
Why?
|
Macrophage Activation | 1 | 2006 | 554 | 0.050 |
Why?
|
Cricetinae | 3 | 2002 | 2427 | 0.050 |
Why?
|
Hemangiosarcoma | 1 | 2005 | 216 | 0.050 |
Why?
|
Immunologic Deficiency Syndromes | 2 | 2003 | 557 | 0.050 |
Why?
|
Immunoenzyme Techniques | 3 | 2015 | 1705 | 0.050 |
Why?
|
Testis | 1 | 2006 | 794 | 0.050 |
Why?
|
Wounds and Injuries | 4 | 1988 | 2477 | 0.050 |
Why?
|
Complementarity Determining Regions | 1 | 2003 | 149 | 0.050 |
Why?
|
Retina | 1 | 1993 | 2635 | 0.050 |
Why?
|
Gastritis | 1 | 2004 | 198 | 0.050 |
Why?
|
Receptors, CCR8 | 1 | 2022 | 28 | 0.050 |
Why?
|
Immunotherapy, Adoptive | 1 | 2012 | 1454 | 0.050 |
Why?
|
Antigens, Viral | 1 | 2006 | 980 | 0.050 |
Why?
|
Models, Biological | 4 | 2010 | 9467 | 0.050 |
Why?
|
Cross Reactions | 1 | 2004 | 818 | 0.050 |
Why?
|
Acetylglucosamine | 1 | 2003 | 189 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 2895 | 0.050 |
Why?
|
Cell Communication | 2 | 2006 | 1653 | 0.050 |
Why?
|
Vincristine | 1 | 2004 | 1039 | 0.050 |
Why?
|
Spleen | 6 | 1991 | 2298 | 0.050 |
Why?
|
Chemokines | 1 | 2006 | 962 | 0.050 |
Why?
|
Ovary | 1 | 2006 | 958 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2015 | 39261 | 0.050 |
Why?
|
Administration, Topical | 1 | 2003 | 697 | 0.050 |
Why?
|
Gene Library | 1 | 2004 | 1060 | 0.050 |
Why?
|
Incidence | 2 | 2019 | 21392 | 0.050 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2012 | 1406 | 0.050 |
Why?
|
Retinoid X Receptors | 1 | 2001 | 91 | 0.050 |
Why?
|
Mice, Inbred CBA | 4 | 1985 | 436 | 0.050 |
Why?
|
Alveolar Bone Loss | 1 | 2004 | 390 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9276 | 0.050 |
Why?
|
Neuraminidase | 1 | 2001 | 200 | 0.050 |
Why?
|
Shock, Septic | 2 | 2000 | 761 | 0.050 |
Why?
|
Reference Values | 2 | 2000 | 4925 | 0.050 |
Why?
|
Palatine Tonsil | 1 | 2001 | 193 | 0.050 |
Why?
|
Retroviridae | 1 | 2003 | 850 | 0.050 |
Why?
|
Receptors, Notch | 1 | 2005 | 743 | 0.050 |
Why?
|
Protein Isoforms | 2 | 2005 | 1697 | 0.050 |
Why?
|
Dexamethasone | 1 | 1988 | 1927 | 0.040 |
Why?
|
Phototherapy | 1 | 2023 | 368 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2007 | 2698 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2013 | 3598 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3426 | 0.040 |
Why?
|
HLA Antigens | 1 | 2005 | 1368 | 0.040 |
Why?
|
RNA | 2 | 2003 | 2722 | 0.040 |
Why?
|
Water | 1 | 2006 | 1407 | 0.040 |
Why?
|
Prednisone | 1 | 2004 | 1565 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2004 | 1832 | 0.040 |
Why?
|
Organ Culture Techniques | 3 | 2003 | 796 | 0.040 |
Why?
|
Protein Subunits | 1 | 2003 | 943 | 0.040 |
Why?
|
Genes, bcl-2 | 1 | 1999 | 119 | 0.040 |
Why?
|
Streptococcus pyogenes | 1 | 2022 | 294 | 0.040 |
Why?
|
Butterflies | 1 | 2019 | 7 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 4938 | 0.040 |
Why?
|
Cell Line, Transformed | 2 | 1993 | 869 | 0.040 |
Why?
|
Immunoglobulins | 1 | 2022 | 859 | 0.040 |
Why?
|
Genetic Vectors | 2 | 2012 | 3380 | 0.040 |
Why?
|
Crosses, Genetic | 2 | 2000 | 751 | 0.040 |
Why?
|
Protein Kinases | 1 | 2006 | 1612 | 0.040 |
Why?
|
Sunburn | 1 | 2000 | 156 | 0.040 |
Why?
|
Genomics | 1 | 2015 | 5794 | 0.040 |
Why?
|
Chemokine CCL5 | 2 | 2016 | 215 | 0.040 |
Why?
|
Immunomagnetic Separation | 1 | 1999 | 79 | 0.040 |
Why?
|
Moths | 1 | 2019 | 81 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8056 | 0.040 |
Why?
|
Baculoviridae | 1 | 2019 | 115 | 0.040 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2014 | 772 | 0.040 |
Why?
|
Prospective Studies | 2 | 2020 | 54303 | 0.040 |
Why?
|
Hemorheology | 1 | 1999 | 144 | 0.040 |
Why?
|
Hydrocortisone | 1 | 1986 | 1803 | 0.040 |
Why?
|
Sepsis | 2 | 1991 | 2592 | 0.040 |
Why?
|
beta Carotene | 1 | 2000 | 524 | 0.040 |
Why?
|
Genes, ras | 1 | 2001 | 655 | 0.040 |
Why?
|
Reactive Oxygen Species | 2 | 2017 | 2138 | 0.040 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2001 | 545 | 0.040 |
Why?
|
Hematopoiesis | 1 | 1988 | 2050 | 0.040 |
Why?
|
Single-Strand Specific DNA and RNA Endonucleases | 2 | 1988 | 31 | 0.040 |
Why?
|
Second Messenger Systems | 1 | 2019 | 202 | 0.040 |
Why?
|
Ear, External | 1 | 1999 | 164 | 0.040 |
Why?
|
Foreskin | 1 | 2018 | 31 | 0.040 |
Why?
|
Epithelium | 5 | 1992 | 1605 | 0.040 |
Why?
|
Hypohidrosis | 1 | 1998 | 29 | 0.040 |
Why?
|
Cytomegalovirus Infections | 1 | 2004 | 831 | 0.040 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 1998 | 317 | 0.040 |
Why?
|
Melanocytes | 2 | 2012 | 512 | 0.040 |
Why?
|
Hypersensitivity, Delayed | 1 | 1999 | 490 | 0.040 |
Why?
|
Culture Media, Serum-Free | 1 | 1997 | 148 | 0.040 |
Why?
|
Receptors, Interleukin-1 Type II | 1 | 1997 | 11 | 0.040 |
Why?
|
Genes, Viral | 1 | 2019 | 650 | 0.040 |
Why?
|
Immunoblotting | 2 | 1998 | 1649 | 0.040 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2004 | 1131 | 0.040 |
Why?
|
Survival Analysis | 1 | 2010 | 10182 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 1 | 2003 | 2569 | 0.040 |
Why?
|
Mutagenesis | 1 | 2001 | 1234 | 0.040 |
Why?
|
Kaposi Varicelliform Eruption | 1 | 2017 | 47 | 0.040 |
Why?
|
Blood Cells | 1 | 1999 | 305 | 0.030 |
Why?
|
Receptors, HIV | 1 | 1997 | 159 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2010 | 7593 | 0.030 |
Why?
|
Kinetics | 5 | 1998 | 6377 | 0.030 |
Why?
|
Transplantation, Homologous | 2 | 2004 | 4810 | 0.030 |
Why?
|
Antibody Specificity | 2 | 1998 | 1060 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2001 | 1529 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2004 | 2693 | 0.030 |
Why?
|
Transfection | 3 | 1993 | 5781 | 0.030 |
Why?
|
Chemokine CXCL1 | 1 | 1996 | 106 | 0.030 |
Why?
|
Sweat Gland Neoplasms | 1 | 1998 | 117 | 0.030 |
Why?
|
Sjogren's Syndrome | 1 | 1998 | 235 | 0.030 |
Why?
|
Peptide Fragments | 2 | 2001 | 5125 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2000 | 618 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2006 | 2802 | 0.030 |
Why?
|
Integrin alpha2 | 1 | 1995 | 39 | 0.030 |
Why?
|
Cell Aggregation | 1 | 2016 | 239 | 0.030 |
Why?
|
Substance P | 1 | 2017 | 333 | 0.030 |
Why?
|
Chemotactic Factors | 1 | 1996 | 196 | 0.030 |
Why?
|
Leukemia, Experimental | 1 | 2016 | 225 | 0.030 |
Why?
|
Ear | 1 | 1996 | 172 | 0.030 |
Why?
|
Cell Size | 1 | 1997 | 624 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2008 | 3539 | 0.030 |
Why?
|
Young Adult | 6 | 2020 | 58741 | 0.030 |
Why?
|
Organ Specificity | 2 | 2000 | 1955 | 0.030 |
Why?
|
Environmental Pollutants | 1 | 2005 | 1266 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2019 | 1167 | 0.030 |
Why?
|
Immune Evasion | 1 | 2019 | 362 | 0.030 |
Why?
|
Sialomucins | 1 | 1994 | 18 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2024 | 80372 | 0.030 |
Why?
|
Gelsolin | 1 | 1995 | 189 | 0.030 |
Why?
|
Efferent Pathways | 1 | 1995 | 165 | 0.030 |
Why?
|
Bone Marrow Cells | 2 | 2002 | 2414 | 0.030 |
Why?
|
Endonucleases | 2 | 1988 | 370 | 0.030 |
Why?
|
Cell Membrane | 3 | 1997 | 3682 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2013 | 17790 | 0.030 |
Why?
|
Nails | 1 | 2016 | 295 | 0.030 |
Why?
|
Integrin alpha Chains | 1 | 2015 | 95 | 0.030 |
Why?
|
Afferent Pathways | 1 | 1995 | 299 | 0.030 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 1997 | 691 | 0.030 |
Why?
|
Time Factors | 7 | 2018 | 40165 | 0.030 |
Why?
|
Isoquinolines | 1 | 2016 | 353 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2015 | 2873 | 0.030 |
Why?
|
Saphenous Vein | 1 | 1997 | 537 | 0.030 |
Why?
|
NADP | 1 | 2015 | 223 | 0.030 |
Why?
|
Mites | 1 | 1994 | 46 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 2019 | 1982 | 0.030 |
Why?
|
Triazines | 2 | 2007 | 310 | 0.030 |
Why?
|
Restriction Mapping | 1 | 1994 | 852 | 0.030 |
Why?
|
Blotting, Northern | 1 | 1995 | 1543 | 0.030 |
Why?
|
Umbilical Veins | 1 | 1994 | 426 | 0.030 |
Why?
|
Autoradiography | 1 | 1994 | 730 | 0.030 |
Why?
|
Isoantigens | 1 | 1996 | 552 | 0.030 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 1997 | 824 | 0.030 |
Why?
|
Genes, p53 | 1 | 2016 | 713 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 368 | 0.030 |
Why?
|
STAT6 Transcription Factor | 1 | 2014 | 193 | 0.030 |
Why?
|
Peptides, Cyclic | 1 | 1995 | 392 | 0.030 |
Why?
|
Efficiency, Organizational | 1 | 2018 | 697 | 0.030 |
Why?
|
Depsipeptides | 1 | 2014 | 95 | 0.030 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 412 | 0.030 |
Why?
|
Macromolecular Substances | 1 | 1995 | 1433 | 0.030 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1993 | 217 | 0.030 |
Why?
|
Pigment Epithelium of Eye | 1 | 1993 | 209 | 0.030 |
Why?
|
Hair | 1 | 2016 | 497 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2014 | 3442 | 0.030 |
Why?
|
Leukocytosis | 1 | 1994 | 251 | 0.030 |
Why?
|
Monophenol Monooxygenase | 1 | 2012 | 74 | 0.030 |
Why?
|
Scalp | 1 | 1995 | 389 | 0.030 |
Why?
|
Herpes Simplex | 1 | 2016 | 478 | 0.030 |
Why?
|
Glutathione | 1 | 2015 | 582 | 0.030 |
Why?
|
Microscopy, Fluorescence | 2 | 2014 | 2651 | 0.030 |
Why?
|
Immunotherapy | 1 | 2008 | 4642 | 0.030 |
Why?
|
Culture Techniques | 1 | 1993 | 530 | 0.030 |
Why?
|
Chromogenic Compounds | 1 | 2012 | 31 | 0.030 |
Why?
|
alpha-MSH | 1 | 2012 | 71 | 0.030 |
Why?
|
Growth Hormone | 1 | 1994 | 568 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2012 | 5785 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 1997 | 1553 | 0.030 |
Why?
|
Primary Prevention | 1 | 2000 | 1207 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2005 | 4742 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2018 | 2932 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1994 | 1744 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2014 | 9585 | 0.020 |
Why?
|
HSC70 Heat-Shock Proteins | 1 | 2011 | 49 | 0.020 |
Why?
|
DNA, Viral | 1 | 2019 | 2194 | 0.020 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2012 | 257 | 0.020 |
Why?
|
Chymases | 1 | 1991 | 73 | 0.020 |
Why?
|
Antioxidants | 1 | 2000 | 1667 | 0.020 |
Why?
|
Crohn Disease | 1 | 2004 | 2275 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 1993 | 522 | 0.020 |
Why?
|
Introns | 1 | 1994 | 978 | 0.020 |
Why?
|
Adolescent | 6 | 2019 | 87810 | 0.020 |
Why?
|
S-Phase Kinase-Associated Proteins | 1 | 2011 | 90 | 0.020 |
Why?
|
Melanocyte-Stimulating Hormones | 1 | 1991 | 25 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2394 | 0.020 |
Why?
|
Cloning, Molecular | 2 | 2012 | 4169 | 0.020 |
Why?
|
Receptors, Pituitary Hormone | 1 | 1991 | 29 | 0.020 |
Why?
|
Heart Diseases | 1 | 2004 | 2809 | 0.020 |
Why?
|
Limit of Detection | 1 | 2012 | 280 | 0.020 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2013 | 881 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 2005 | 2882 | 0.020 |
Why?
|
Cytoplasm | 1 | 1995 | 1516 | 0.020 |
Why?
|
NF-kappa B | 1 | 1999 | 2488 | 0.020 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2012 | 306 | 0.020 |
Why?
|
Hydroxamic Acids | 1 | 2014 | 482 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1612 | 0.020 |
Why?
|
Protein Stability | 1 | 2012 | 566 | 0.020 |
Why?
|
Hydrolysis | 1 | 2012 | 665 | 0.020 |
Why?
|
Immunoconjugates | 1 | 1998 | 949 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2011 | 319 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 358 | 0.020 |
Why?
|
Melanins | 1 | 2012 | 291 | 0.020 |
Why?
|
Sequence Analysis, Protein | 1 | 2011 | 258 | 0.020 |
Why?
|
Electronic Health Records | 2 | 2018 | 4775 | 0.020 |
Why?
|
Skin Transplantation | 2 | 2003 | 1083 | 0.020 |
Why?
|
Immunization, Passive | 1 | 1993 | 616 | 0.020 |
Why?
|
Herpesvirus 1, Human | 1 | 2016 | 753 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2012 | 492 | 0.020 |
Why?
|
Europe | 2 | 2007 | 3441 | 0.020 |
Why?
|
Seasons | 2 | 2007 | 1522 | 0.020 |
Why?
|
Antibodies | 3 | 1993 | 2421 | 0.020 |
Why?
|
Treatment Failure | 1 | 2016 | 2648 | 0.020 |
Why?
|
Research Design | 2 | 2016 | 6180 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1135 | 0.020 |
Why?
|
DNA, Complementary | 1 | 1993 | 1991 | 0.020 |
Why?
|
Pigmentation | 1 | 2010 | 144 | 0.020 |
Why?
|
Thrombin | 1 | 2012 | 593 | 0.020 |
Why?
|
HIV | 1 | 1996 | 1579 | 0.020 |
Why?
|
Algorithms | 1 | 2010 | 13981 | 0.020 |
Why?
|
Chromatography, Gel | 2 | 1988 | 645 | 0.020 |
Why?
|
Autoantibodies | 1 | 1998 | 2118 | 0.020 |
Why?
|
Mitogens | 1 | 1989 | 230 | 0.020 |
Why?
|
Complement System Proteins | 1 | 2012 | 782 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2004 | 12965 | 0.020 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2009 | 133 | 0.020 |
Why?
|
Perforin | 1 | 2009 | 167 | 0.020 |
Why?
|
Fresh Water | 1 | 2009 | 82 | 0.020 |
Why?
|
HIV-1 | 2 | 1997 | 6849 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2012 | 11712 | 0.020 |
Why?
|
Models, Molecular | 1 | 2019 | 5434 | 0.020 |
Why?
|
Exons | 1 | 1994 | 2388 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2022 | 3826 | 0.020 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2012 | 646 | 0.020 |
Why?
|
Embryonic and Fetal Development | 1 | 1989 | 420 | 0.020 |
Why?
|
HIV Infections | 3 | 2003 | 17165 | 0.020 |
Why?
|
United States | 4 | 2024 | 72461 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2012 | 1055 | 0.020 |
Why?
|
Gene Dosage | 1 | 2012 | 1218 | 0.020 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 381 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2011 | 747 | 0.020 |
Why?
|
Fingers | 1 | 1991 | 506 | 0.020 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2012 | 611 | 0.020 |
Why?
|
Animals, Newborn | 1 | 1993 | 2672 | 0.020 |
Why?
|
DNA Replication | 2 | 1991 | 1412 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2282 | 0.020 |
Why?
|
2-Methyl-4-chlorophenoxyacetic Acid | 1 | 2007 | 2 | 0.020 |
Why?
|
MART-1 Antigen | 1 | 2007 | 65 | 0.020 |
Why?
|
Dependovirus | 1 | 2012 | 709 | 0.020 |
Why?
|
Plant Physiological Phenomena | 1 | 2007 | 16 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2011 | 2753 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2011 | 2176 | 0.020 |
Why?
|
Isomerism | 1 | 2007 | 197 | 0.020 |
Why?
|
Proteomics | 1 | 2021 | 3817 | 0.020 |
Why?
|
Secretory Rate | 1 | 1986 | 81 | 0.020 |
Why?
|
Water Pollution | 1 | 2007 | 33 | 0.020 |
Why?
|
Aerobiosis | 1 | 2007 | 101 | 0.020 |
Why?
|
Endopeptidases | 1 | 1991 | 772 | 0.020 |
Why?
|
Oncogenes | 1 | 2012 | 1220 | 0.020 |
Why?
|
Species Specificity | 1 | 1991 | 2418 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2012 | 1755 | 0.020 |
Why?
|
Rats | 4 | 1999 | 23711 | 0.020 |
Why?
|
Body Fluids | 1 | 1988 | 319 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2011 | 1745 | 0.020 |
Why?
|
Face | 1 | 2012 | 1017 | 0.020 |
Why?
|
Cell Count | 2 | 2003 | 1835 | 0.020 |
Why?
|
Blister | 1 | 1986 | 86 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 1988 | 1544 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2008 | 551 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2013 | 2897 | 0.020 |
Why?
|
Exudates and Transudates | 1 | 1986 | 175 | 0.020 |
Why?
|
Culture Media | 4 | 1990 | 900 | 0.020 |
Why?
|
Proteome | 1 | 2016 | 1855 | 0.020 |
Why?
|
Alprostadil | 1 | 2005 | 86 | 0.020 |
Why?
|
Camphor | 1 | 2005 | 9 | 0.020 |
Why?
|
Furans | 1 | 2007 | 199 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 1991 | 2234 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2012 | 15289 | 0.020 |
Why?
|
Suppressor Factors, Immunologic | 1 | 1985 | 68 | 0.020 |
Why?
|
Sunlight | 1 | 1987 | 337 | 0.020 |
Why?
|
Medicare | 1 | 2024 | 6786 | 0.020 |
Why?
|
Polymyositis | 1 | 2005 | 75 | 0.020 |
Why?
|
Lipopolysaccharides | 2 | 1994 | 2209 | 0.020 |
Why?
|
Piperazines | 1 | 2016 | 2525 | 0.020 |
Why?
|
Cinnamates | 1 | 2005 | 59 | 0.020 |
Why?
|
Acrylates | 1 | 2005 | 79 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1991 | 3084 | 0.020 |
Why?
|
Luminescence | 1 | 2005 | 133 | 0.020 |
Why?
|
Carbamates | 1 | 2007 | 192 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12808 | 0.020 |
Why?
|
Granulocytes | 1 | 1987 | 551 | 0.020 |
Why?
|
Aging | 1 | 2004 | 8651 | 0.020 |
Why?
|
Drug Synergism | 1 | 1989 | 1754 | 0.020 |
Why?
|
Genotype | 2 | 2012 | 12960 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 1628 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2012 | 1827 | 0.020 |
Why?
|
Chromatography, Thin Layer | 1 | 2004 | 212 | 0.020 |
Why?
|
Chromatography, Gas | 1 | 2004 | 151 | 0.020 |
Why?
|
Child, Preschool | 3 | 2016 | 42063 | 0.020 |
Why?
|
Graft Survival | 1 | 2015 | 3794 | 0.020 |
Why?
|
Leukotriene B4 | 1 | 2005 | 280 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2011 | 3800 | 0.010 |
Why?
|
Benzopyrans | 1 | 2004 | 63 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2803 | 0.010 |
Why?
|
Tetrahydronaphthalenes | 1 | 2004 | 86 | 0.010 |
Why?
|
Pilot Projects | 1 | 2018 | 8555 | 0.010 |
Why?
|
Mutation | 3 | 2014 | 29932 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 2005 | 660 | 0.010 |
Why?
|
DNA | 2 | 1988 | 7233 | 0.010 |
Why?
|
GPI-Linked Proteins | 1 | 2005 | 468 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2012 | 4107 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2012 | 6238 | 0.010 |
Why?
|
Benzoates | 1 | 2005 | 212 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3078 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2012 | 1599 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2012 | 1894 | 0.010 |
Why?
|
Protein Conformation | 1 | 1991 | 3969 | 0.010 |
Why?
|
Antigens, Ly | 1 | 1984 | 292 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 2919 | 0.010 |
Why?
|
Interleukin-23 Subunit p19 | 1 | 2003 | 23 | 0.010 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2003 | 57 | 0.010 |
Why?
|
Osteoblasts | 1 | 1989 | 1142 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2012 | 2717 | 0.010 |
Why?
|
Particle Size | 1 | 2007 | 1644 | 0.010 |
Why?
|
Conservation of Natural Resources | 1 | 2005 | 211 | 0.010 |
Why?
|
Viral Load | 1 | 2012 | 3322 | 0.010 |
Why?
|
Interleukin-8 | 1 | 2005 | 698 | 0.010 |
Why?
|
Epithelial Cells | 3 | 1990 | 3663 | 0.010 |
Why?
|
Cities | 1 | 2005 | 538 | 0.010 |
Why?
|
Mononuclear Phagocyte System | 1 | 1982 | 54 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 1989 | 1797 | 0.010 |
Why?
|
HeLa Cells | 1 | 2008 | 3105 | 0.010 |
Why?
|
Sheep | 1 | 1984 | 1441 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2003 | 680 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2015 | 3224 | 0.010 |
Why?
|
Fluorocarbons | 1 | 2007 | 488 | 0.010 |
Why?
|
Interleukin-23 | 1 | 2003 | 197 | 0.010 |
Why?
|
Benzimidazoles | 1 | 2007 | 858 | 0.010 |
Why?
|
Mice, Nude | 1 | 2008 | 3607 | 0.010 |
Why?
|
Lymphocytes | 2 | 1986 | 2611 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 2005 | 978 | 0.010 |
Why?
|
Atrophy | 1 | 2006 | 1627 | 0.010 |
Why?
|
Major Histocompatibility Complex | 1 | 2004 | 928 | 0.010 |
Why?
|
Hepatitis, Animal | 1 | 2000 | 19 | 0.010 |
Why?
|
Risk Assessment | 3 | 2007 | 24123 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2011 | 4713 | 0.010 |
Why?
|
Propionibacterium acnes | 1 | 2000 | 65 | 0.010 |
Why?
|
Child | 4 | 2016 | 79806 | 0.010 |
Why?
|
Feedback | 1 | 1984 | 791 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8482 | 0.010 |
Why?
|
Peritonitis | 1 | 1982 | 369 | 0.010 |
Why?
|
Thymidine | 2 | 1991 | 299 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2008 | 2379 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 2 | 1992 | 1304 | 0.010 |
Why?
|
Skin Ulcer | 1 | 2000 | 129 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10344 | 0.010 |
Why?
|
Binding Sites, Antibody | 1 | 1998 | 337 | 0.010 |
Why?
|
Magnesium | 1 | 1982 | 810 | 0.010 |
Why?
|
Antibodies, Blocking | 1 | 1998 | 242 | 0.010 |
Why?
|
Chemotactic Factors, Eosinophil | 1 | 1997 | 40 | 0.010 |
Why?
|
Chemokine CCL3 | 1 | 1997 | 84 | 0.010 |
Why?
|
Chemokine CCL11 | 1 | 1997 | 128 | 0.010 |
Why?
|
MicroRNAs | 1 | 2014 | 3790 | 0.010 |
Why?
|
Chemokine CCL4 | 1 | 1997 | 126 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1998 | 866 | 0.010 |
Why?
|
Macrophage Inflammatory Proteins | 1 | 1997 | 121 | 0.010 |
Why?
|
Lichen Planus | 1 | 1998 | 71 | 0.010 |
Why?
|
Regression Analysis | 1 | 2007 | 6360 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2004 | 2192 | 0.010 |
Why?
|
Pemphigus | 1 | 1998 | 116 | 0.010 |
Why?
|
3T3 Cells | 1 | 1998 | 1085 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14660 | 0.010 |
Why?
|
COS Cells | 1 | 1998 | 1129 | 0.010 |
Why?
|
Pemphigoid, Bullous | 1 | 1998 | 114 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2000 | 1792 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1984 | 4899 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6465 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 25942 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2012 | 8950 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 1982 | 1993 | 0.010 |
Why?
|
Infant | 1 | 2016 | 36060 | 0.010 |
Why?
|
Hemorrhage | 1 | 1987 | 3600 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2000 | 3602 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20080 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1994 | 622 | 0.010 |
Why?
|
Virus Integration | 1 | 1995 | 302 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 15789 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2005 | 2159 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 1997 | 951 | 0.010 |
Why?
|
Enterotoxins | 1 | 1994 | 366 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15840 | 0.010 |
Why?
|
Mixed Connective Tissue Disease | 1 | 1991 | 32 | 0.010 |
Why?
|
Gels | 1 | 1992 | 419 | 0.010 |
Why?
|
Laminin | 1 | 1992 | 405 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1992 | 778 | 0.010 |
Why?
|
Raynaud Disease | 1 | 1991 | 79 | 0.010 |
Why?
|
Phagocytes | 2 | 1982 | 296 | 0.010 |
Why?
|
Ploidies | 1 | 1990 | 275 | 0.010 |
Why?
|
Graft Rejection | 1 | 2003 | 4426 | 0.010 |
Why?
|
Isoelectric Focusing | 1 | 1989 | 160 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20509 | 0.010 |
Why?
|
Transplantation, Isogeneic | 1 | 1988 | 248 | 0.000 |
Why?
|
Peritoneal Cavity | 1 | 1988 | 138 | 0.000 |
Why?
|
Embryo Implantation | 1 | 1989 | 270 | 0.000 |
Why?
|
Concanavalin A | 1 | 1987 | 190 | 0.000 |
Why?
|
Fixatives | 1 | 1987 | 91 | 0.000 |
Why?
|
Dietary Supplements | 1 | 2000 | 3392 | 0.000 |
Why?
|
Phytohemagglutinins | 1 | 1986 | 168 | 0.000 |
Why?
|
Molecular Biology | 1 | 1990 | 580 | 0.000 |
Why?
|
Rats, Inbred Lew | 1 | 1988 | 1154 | 0.000 |
Why?
|
Liver | 1 | 1982 | 7509 | 0.000 |
Why?
|
Indomethacin | 1 | 1986 | 326 | 0.000 |
Why?
|
Blastocyst | 1 | 1989 | 433 | 0.000 |
Why?
|
Double-Blind Method | 1 | 2000 | 12427 | 0.000 |
Why?
|
Fluorescent Antibody Technique | 1 | 1989 | 2471 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1989 | 10827 | 0.000 |
Why?
|
Fibrosis | 1 | 1991 | 2042 | 0.000 |
Why?
|
Biological Transport, Active | 1 | 1982 | 327 | 0.000 |
Why?
|
Endometriosis | 1 | 1989 | 874 | 0.000 |
Why?
|
Aspartate Aminotransferases | 1 | 1982 | 416 | 0.000 |
Why?
|
Indocyanine Green | 1 | 1982 | 236 | 0.000 |
Why?
|
Alanine Transaminase | 1 | 1982 | 606 | 0.000 |
Why?
|
Alkaline Phosphatase | 1 | 1982 | 865 | 0.000 |
Why?
|
Cohort Studies | 1 | 2000 | 41335 | 0.000 |
Why?
|
Wound Healing | 1 | 1988 | 2788 | 0.000 |
Why?
|
Calcium | 1 | 1989 | 5725 | 0.000 |
Why?
|